Breaking News Instant updates and real-time market news.

KEM

Kemet

$23.78

-0.255 (-1.06%)

, BCOV

Brightcove

$10.05

-0.1 (-0.99%)

04:55
06/13/18
06/13
04:55
06/13/18
04:55

Stifel to hold a conference

2018 Cross Sector Insight Conference will be held in Boston on June 11-13.

KEM

Kemet

$23.78

-0.255 (-1.06%)

BCOV

Brightcove

$10.05

-0.1 (-0.99%)

FTV

Fortive

$78.30

-0.08 (-0.10%)

COHU

Cohu

$24.95

0.45 (1.84%)

NWY

New York & Co.

$4.13

-0.115 (-2.71%)

TNET

TriNet

$54.88

-0.03 (-0.05%)

GTT

GTT Communications

$51.15

1.15 (2.30%)

GPX

GP Strategies

$19.65

(0.00%)

GLUU

Glu Mobile

$5.88

0.38 (6.91%)

ROL

Rollins

$52.79

0.455 (0.87%)

SILC

Silicom

$39.99

0.48 (1.21%)

FSS

Federal Signal

$24.02

-0.26 (-1.07%)

TTS

Tile Shop

$8.15

0.25 (3.16%)

ULTI

Ultimate Software

$270.46

5.43 (2.05%)

AEGN

Aegion

$25.98

0.01 (0.04%)

SUMR

Summer Infant

$1.33

0.05 (3.91%)

CAT

Caterpillar

$157.49

1.21 (0.77%)

BLKB

Blackbaud

$105.57

1.75 (1.69%)

IRM

Iron Mountain

$35.02

0.385 (1.11%)

NCLH

Norwegian Cruise Line

$52.73

0.47 (0.90%)

  • 13

    Jun

  • 13

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

KEM Kemet
$23.78

-0.255 (-1.06%)

BCOV Brightcove
$10.05

-0.1 (-0.99%)

10/27/17
NORL
10/27/17
UPGRADE
NORL
Outperform
Brightcove upgraded to Outperform from Market Perform at Northland
FTV Fortive
$78.30

-0.08 (-0.10%)

03/08/18
SPHN
03/08/18
NO CHANGE
Target $52
SPHN
Overweight
Altra Industrial deal makes strategic sense, but raises risk, says Stephens
After Altra Industrial Motion (AIMC) announced an agreement to combine Altra with four operating companies from Fortive's (FTV) Automation and Specialty platform, Stephens analyst Matt Duncan said he likes the deal from a strategic standpoint and sees significant long-term earnings upside from the transaction. However, the deal increases the risk profile for Altra shareholders "a good bit" due to the high leverage at closing and "rich price tag." Duncan keeps an Overweight rating on Altra shares, but lowered his price target to $52 from $56 as he thinks the "short-term shift to the risk profile can't be ignored."
03/09/18
JPMS
03/09/18
DOWNGRADE
Target $84
JPMS
Neutral
Fortive downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Steve Tusa downgraded Fortive to Neutral with an $84 price target. The analyst believes the current valuation already reflects the company's upcoming capital deployment. He believes, however, that Fortive's "franchise quality remains intact."
02/15/18
LEHM
02/15/18
INITIATION
Target $86
LEHM
Overweight
Fortive initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Fortive with an Overweight rating and $86 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
03/08/18
BARD
03/08/18
UPGRADE
Target $57
BARD
Outperform
Altra Industrial Motion upgraded to Outperform at Baird
As reported previously, Baird analyst Michael Halloran upgraded Altra Industrial Motion (AIMC) to Outperform from Neutral. The analyst believes 2018 will be a year of transformation following its deal with Fortive (FTV). The analyst said the deal synergies appear reasonable and the potential accretion will be significant. Halloran raised his price target to $57 from $50 on Altra Industrial shares.
COHU Cohu
$24.95

0.45 (1.84%)

05/09/18
RILY
05/09/18
DOWNGRADE
Target $14
RILY
Neutral
Xcerra downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Craig Ellis downgraded Xcerra (XCRA) to Hold and lowered his price target for the shares to $14 from $15 to reflect the takeover by Cohu (COHU).
05/09/18
NEED
05/09/18
DOWNGRADE
NEED
Hold
Xcerra downgraded to Hold at Needham on acquisition
As reported earlier, Needham analyst Y. Edwin Mok downgraded Xcerra (XCRA) to Hold from Buy after the announcement that it is being acquired by Cohu for $9 per share in cash and 0.21 a share of Cohu (COHU) stock. Mok says there is limited upside from the deal's combined price of $13.92 per share and does not see the possibility of another bidder emerging. While the analyst expects some regulatory scrutiny given the product overlaps of the two companies, he ultimately sees the deal winning approval.
05/29/18
STFL
05/29/18
DOWNGRADE
Target $14
STFL
Hold
Xcerra downgraded to Hold from Buy at Stifel
Stifel analyst Patrick Ho downgraded Xcerra (XCRA) to Hold from Buy citing his belief that its acquisition by Cohu (COHU) will be completed before year end. The analyst, who raised his price target for Xcerra to $14 from $13, does not believe there will be any competitive bids and sees the deal passing U.S. and European regulatory hurdles.
05/25/18
DADA
05/25/18
NO CHANGE
Target $14
DADA
Neutral
Xcerra attractive in either scenario of Cohu deal uncertainty, says DA Davidson
DA Davidson analyst Thomas Diffely keeps his Neutral rating and $14 price target on Xcerra (XCRA), saying that its "solid" results and momentum from recent share gains make it an attractive investment regardless of the outcome of the pending Cohu (COHU) acquisition. The analyst notes that the regulatory process has been unpredictable over the past year, but he is positive on the stock based on the "combination of a somewhat modest premium to be paid by Cohu and the strong underlying business activity".
NWY New York & Co.
$4.13

-0.115 (-2.71%)

04/02/18
ROTH
04/02/18
INITIATION
Target $4.5
ROTH
Buy
New York & Co. initiated with a Buy at Roth Capital
Roth Capital analyst Dave King started New York & Co. with a Buy rating and $4.50 price target, noting that the company's traffic and average ticket are increasing as it shrinks its store base and he believes its margins should continue to improve as it drives significant growth in its e-commerce business. King also thinks management's guidance looks conservative given the easy comparisons the company faces in the first half of the year.
04/02/18
04/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Karyopharm (KPTI) assumed with an Outperform at Leerink. 2. BioXcel Therapeutics (BTAI) was initiated with a Buy at Canaccord and UBS, an Outperform at BMO Capital, and an Overweight at Barclays. 3. New York & Co. (NWY) initiated with a Buy at Roth Capital. 4. Sellas Life Sciences (SLS) initiated with a Buy at H.C. Wainwright. 5. Hanesbrands (HBI) initiated with a Neutral at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TNET TriNet
$54.88

-0.03 (-0.05%)

04/04/18
MSCO
04/04/18
UPGRADE
Target $46
MSCO
Equal Weight
TriNet upgraded to Equal Weight on better margins, tax reform at Morgan Stanley
As previously reported, Morgan Stanley analyst Vasundhara Govil upgraded TriNet to Equal Weight from Underweight, stating that the company's net insurance margins outperformance has been more sustainable than anticipated. The analyst, who also cites tax reform benefits, raised the price target on TriNet shares to $46 from $32.
04/04/18
MSCO
04/04/18
UPGRADE
MSCO
Equal Weight
TriNet upgraded to Equal Weight from Underweight at Morgan Stanley
08/22/17
08/22/17
DOWNGRADE
Target $31

Underweight
TriNet downgraded to Underweight at Morgan Stanley
As previously reported, Morgan Stanley downgraded TriNet to Underweight from Equal Weight and raised its price target to $27 from $31. Analyst Danyal Hussain said shares have overshot to the upside as insurance performance is masking underlying margins and sees risk into 2018 as the company continues to invest heavily in product, compliance, and sales.
08/22/17
MSCO
08/22/17
DOWNGRADE
MSCO
Underweight
TriNet downgraded to Underweight from Equal Weight at Morgan Stanley
GTT GTT Communications
$51.15

1.15 (2.30%)

05/04/18
KEYB
05/04/18
UPGRADE
KEYB
Overweight
GTT Communications upgraded to Overweight from Sector Weight at KeyBanc
05/04/18
KEYB
05/04/18
UPGRADE
Target $57
KEYB
Overweight
GTT Communications upgraded to Overweight with $57 target at KeyBanc
KeyBanc analyst Brandon Nispel upgraded GTT Communications to Overweight with a $57 price target. The analyst believes the current valuation offers an attractive entry point. The uncertainty created by the Interoute deal has created an opportunity for investors, Nispel tells investors in a research note.
05/01/18
05/01/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apple (AAPL) initiated with a Buy at DA Davidson. 2. Spotify (SPOT) initiated with a Neutral at Buckingham. 3. Ares Management (ARES) initiated with an Outperform at Oppenheimer. 4. GTT Communications (GTT) initiated with an Outperform at Raymond James. 5. Electronic Arts (EA) was initiated with an Overweight at JPMorgan while Activision Blizzard (ATVI) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/30/18
RAJA
04/30/18
INITIATION
RAJA
Outperform
GTT Communications initiated with an Outperform at Raymond James
GPX GP Strategies
$19.65

(0.00%)

05/04/18
BRRR
05/04/18
NO CHANGE
Target $25
BRRR
Outperform
Barrington optimistic on GP Strategies changes despite near-term drag on results
Barrington analyst Alexander Paris Jr. said he remains optimistic about the recent changes in management and corporate structure implemented by GP Strategies, though he notes its reorganization and restructuring activities are having a near-term transitional effect on its financial results. Following the company's Q1 report and call, he lowered his FY18 revenue and EPS estimates and cut his price target on the stock to $25 from $30, but he maintains an Outperform rating on GP Strategies shares.
01/04/18
RILY
01/04/18
UPGRADE
Target $28
RILY
Buy
GP Strategies upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Kevin Liu upgraded GP Strategies to Buy and raised his price target for the shares to $28 from $24.50. The analyst upped his estimates for the company following the recent organizational changes.
GLUU Glu Mobile
$5.88

0.38 (6.91%)

06/08/18
ROTH
06/08/18
NO CHANGE
Target $6.5
ROTH
Buy
Glu Mobile weakness a buying opportunity, says Roth Capital
Roth Capital analyst Darren Aftahi believes recent weakness in shares of Glu Mobile may be partially due to a TwitchTV live update suggesting a delay for the re-launch of Racing Rivals 7.0 to address some last minute bug fixes. The analyst, who said he models no revenue contribution from this game in 2018, sees the weakness as a buying opportunity and keeps a Buy rating and $6.50 price target on Glu Mobile shares.
10/12/17
BNCH
10/12/17
UPGRADE
BNCH
Buy
Glu Mobile upgraded to Buy from Hold at Benchmark
10/12/17
10/12/17
UPGRADE
Target $6

Buy
Glu Mobile upgraded to Buy at Benchmark
As previously reported, Benchmark analyst Mike Hickey upgraded Glu Mobile to Buy from Hold, saying he believes a turnaround is taking shape and that he is "cautiously optimistic" on the upcoming launch of "The Swift Life," a social platform from Taylor Swift, who has several hundred million social followers. Hickey set a $6 price target on Glu Mobile shares.
ROL Rollins
$52.79

0.455 (0.87%)

05/31/18
05/31/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wyndham Hotels & Resorts (WH) initiated with a Buy at Jefferies and an Overweight at JPMorgan. 2. Nxt-ID (NXTD) initiated with a Buy at Euro Pacific. 3. Infinity Pharmaceuticals (INFI) initiated with a Buy at Seaport Global. 4. Edwards Lifesciences (EW) and Medtronic (MDT) were initiated with an Outperform at Raymond James. 5. Rollins (ROL) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/31/18
STFL
05/31/18
INITIATION
Target $50
STFL
Hold
Rollins initiated with a Hold at Stifel
Stifel analyst Michael Hoffman started Rollins with a Hold rating and $50 price target, noting that the leader in termite and pest control produces "superior" free cash flow and pays out over 55% of that free cash flow in a dividend. Hoffman said he would view a selloff in the shares as an entry point into the stock.
05/09/18
05/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cleveland-Cliffs (CLF) initiated with a Buy at Seaport Global. 2. Amneal Pharmaceuticals (AMRX) initiated with a Buy at Deutsche Bank. 3. Iridium (IRDM) initiated with a Buy at BWS Financial. 4. ServiceMaster (SERV) initiated with a Buy at Buckingham while Rollins (ROL) was initiated with a Neutral at Buckingham. 5. Eiger BioPharmaceuticals (EIGR) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/18
BUCK
05/09/18
INITIATION
Target $50
BUCK
Neutral
Rollins initiated with a Neutral at Buckingham
Buckingham analyst James Clement initiated Rollins with a Neutral and $50 price target telling investors shares are priced to perfection with little upside at current levels.
SILC Silicom
$39.99

0.48 (1.21%)

01/12/18
NEED
01/12/18
NO CHANGE
Target $90
NEED
Buy
Silicom price target raised to $90 from $75 at Needham
Needham analyst Alex Henderson raised his price target on Silicom to $90, citing strong ramp and lengthening visibility from the company's deals signed over the past year. The analyst says the booked deals could double the size of the company over the next two years as they ramp to full production in that time span. Henderson keeps his Buy rating on Silicom.
07/25/17
NEED
07/25/17
NO CHANGE
Target $67
NEED
Buy
Silicom price target raised to $67 from $60 at Needham
Needham analyst Alex Henderson raised his price target for Silicom to $67 from $60 saying the company is at an inflection point where numerous demand drivers are poised to drive significantly higher rates of growth. The analyst reiterates a Buy rating on the shares.
03/14/18
NEED
03/14/18
NO CHANGE
Target $50
NEED
Buy
Silicom price target lowered to $50 from $90 at Needham
Needham analyst Alex Henderson lowered his price target on Silicom to $50 to reflect the impact and the selloff in the stock price from one of the company's major cloud customers pulling out of deploying its technology. Henderson contends that the decision is driven by the customer's problem in implementing the solution rather than the product's intrinsic value. The analyst keeps his Buy rating on Silicom, adding that the stock price reaction "looks overdone".
FSS Federal Signal
$24.02

-0.26 (-1.07%)

02/20/18
SIDC
02/20/18
INITIATION
Target $21
SIDC
Neutral
Federal Signal initiated with a Neutral at Sidoti
Sidoti initiated Federal Signal with a Neutral and $21 price target.
TTS Tile Shop
$8.15

0.25 (3.16%)

10/27/17
LOOP
10/27/17
NO CHANGE
LOOP
Hold
Loop says Tile Shop CEO pick 'far more important' than debate over resignation
Loop Capital analyst Anthony Chukumba said he was a bit surprised that Tile Shop CEO Chris Homeister has resigned, but thinks it is "far more important" to see who his permanent replacement is than to debate whether Homeister was pushed out prematurely. Chukumba keeps a Hold rating on Tile Shop shares.
10/17/17
LOOP
10/17/17
NO CHANGE
Target $8
LOOP
Hold
Loop Capital 'no more confident' in Tile Shop after earnings call
Loop Capital analyst Anthony Chukumba said he is "no more confident" in Tile Shop's turnaround prospects after listening to the company's earnings call than he was before it. The analyst, who is concerned about future profitability and the more intense competitive environment, cut his price target on Tile Shop to $8 from $9 and keeps a Hold rating on the stock.
02/22/18
LOOP
02/22/18
NO CHANGE
Target $5
LOOP
Hold
Tile Shop price target lowered to $5 from $8 at Loop Capital
Loop Capital analyst Anthony Chukumba lowered his price target on Tile Shop to $5, saying the company's "difficult" Q4 results give him less confidence about its turnaround prospects. Chukumba questions "how much of Tile Shop's struggles is due to increasingly high quality, low cost imitations of its premium products that are 'good enough' for most value conscious consumers". The analyst keeps his Hold rating, citing in part the 27% decline in the stock price following Q4 earnings.
02/22/18
STFL
02/22/18
NO CHANGE
Target $6.5
STFL
Hold
Tile Shop price target cut to $6.50 after 'clear disappointment' in Q4 at Stifel
Stifel analyst John Baugh said Tile Shop's Q4 results were "clearly a disappointment" and he noted that management discussed a major shift in strategy during the associated call. With the company shifting focus to the higher end of the pricing spectrum and product differentiation and stating it will invest meaningfully in SG&A in 2018, Baugh remains cautious. He lowered his price target on Tile Shop shares to $6.50 from $10 and keeps a Hold rating on the stock.
ULTI Ultimate Software
$270.46

5.43 (2.05%)

05/02/18
FBCO
05/02/18
NO CHANGE
Target $280
FBCO
Outperform
Ultimate Software price target raised to $280 from $255 at Credit Suisse
Credit Suisse analyst Michael Nemeroff raised his price target for Ultimate Software to $280 from $255, citing a clean beat with a CFO transition, new international aspirations, and an eye on M&A. The analyst reiterates an Outperform rating on the shares.
05/02/18
WEDB
05/02/18
NO CHANGE
Target $260
WEDB
Neutral
Ultimate Software price target raised to $260 from $255 at Wedbush
Wedbush analyst Steve Koenig raised his price target for Ultimate Software to $260 from $255 saying it continues to benefit from a strong demand environment, solid market position, and good execution, as evidenced by Q1 results. The analyst reiterates a Neutral rating on the shares.
05/02/18
NEED
05/02/18
NO CHANGE
Target $280
NEED
Buy
Ultimate Software price target raised to $280 from $250 at Needham
Needham analyst Scott Berg raised his price target on Ultimate Software to $280, saying the company's Q1 outperformance on revenues was its best in three years. The analyst also expects the company's CFO transition to be seamless, while noting that its push into European markets can be a "significant catalyst" in achieving its $3B revenue target. Berg keeps his Buy rating on Ultimate Software.
05/02/18
RHCO
05/02/18
NO CHANGE
Target $280
RHCO
Buy
Ultimate Software price target raised to $280 from $250 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Ultimate Software to $280 from $250 and kept his Buy rating after the company's Q1 results, saying the upside in recurring revenues produced better than expected margins and cash flows. The analyst notes that the management's commentary about the pipeline was also positive, supporting his view that the company's guidance for FY18 is on the conservative side.
AEGN Aegion
$25.98

0.01 (0.04%)

10/04/17
HDLY
10/04/17
UPGRADE
HDLY
Buy
Aegion upgraded to Buy from Neutral at Hilliard Lyons
Hilliard Lyons analyst Spencer Joyce upgraded Aegion to Buy with a $26 price target citing valuation.
10/03/17
10/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Aegion (AEGN) downgraded to Hold from Buy at Craig-Hallum with analyst Eric Stine citing valuation following the third quarter update and with restructuring a work in progress. 2. Urban Outfitters (URBN) downgraded to Sell from Hold at Deutsche Bank with analyst Tiffany Kanaga saying the valuation has "stretched to elevated levels." 3. Tile Shop (TTS) downgraded to Underperform from Market Perform at Telsey Advisory with analyst Joseph Feldman saying he is concerned the deceleration will continue for several quarters given weakness was attributed to increased competition that led to the company to increase promotions. 4. Lear (LEA) downgraded to Neutral from Buy at UBS with analyst Colin Langan saying the E-System spin upside seems already priced in following the recent share rally. 5. MGM Resorts (MGM) downgraded to Neutral from Positive at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
10/03/17
DOWNGRADE
Target $25

Hold
Aegion downgraded to Hold at Craig-Hallum
As previously reported, Craig-Hallum analyst Eric Stine downgraded Aegion to a Hold from a Buy, with a $25 price target, on valuation following Q3 update and with restructuring a work in progress.
12/21/17
HDLY
12/21/17
DOWNGRADE
HDLY
Neutral
Aegion downgraded to Neutral from Buy at Hilliard Lyons
Hilliard Lyons analyst Spencer Joyce downgraded Aegion to Neutral citing more balanced risk/reward near-term based on sentiment and valuation.
SUMR Summer Infant
$1.33

0.05 (3.91%)

CAT Caterpillar
$157.49

1.21 (0.77%)

05/03/18
05/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Estee Lauder (EL) downgraded to Hold from Buy at Jefferies with analyst Stephanie Wissink saying she sees signs of growth rate moderation and rising customer level costs following third quarter results. 2. Malibu Boats (MBUU) downgraded to Market Perform from Outperform at Wells Fargo analyst Timothy Conder citing valuation. 3. Cummins (CMI) and Caterpillar (CAT) were downgraded to Neutral from Buy at BofA/Merrill. 4. Esperion (ESPR) downgraded to Underweight from Neutral at JPMorgan with analyst Jessica Fye saying it will be difficult for the stock to "dig out from" the recent pullback following the Phase III long-term safety study of bempedoic acid, which included a "curious death imbalance." 5. Habit Restaurants (HABT) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh saying he sees limited visibility following the company's Q1 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/18
BOFA
05/03/18
DOWNGRADE
Target $156
BOFA
Neutral
Caterpillar downgraded to Neutral on peak earnings, valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Caterpillar to Neutral from Buy. Analyst Ross Gilardi believes leading indicators are looking "toppy," while Caterpillar's retail sales growth is slowing and Class 8 truck orders are at a high. The analyst notes Machinery stocks are highly correlated to ISM, which has dipped each of the last 3 months following a potential peak in February at the 60.8 reading, and expects multiple to continue to de-rate. Gilardi expects Caterpillar's earnings to top out in 2021 at approximately $15/share, implying a price target of $156, reduced from $172.
05/03/18
BOFA
05/03/18
DOWNGRADE
BOFA
Neutral
Caterpillar downgraded to Neutral from Buy at BofA/Merrill
05/02/18
BUCK
05/02/18
DOWNGRADE
Target $160
BUCK
Neutral
Cummins downgraded to Neutral at Buckingham on product campaign uncertainty
As reported earlier, Buckingham Research analyst Neil Frohnapple downgraded Cummins (CMI) to Neutral from Buy and lowered his price target to $160 from $205. The analyst attributes the rating change to the "ongoing uncertainty related to a product campaign that could be an overhang for another two quarters", citing the company's latest estimate of related charges up to $400M or above $2 in EPS per share. Frohnapple says the risk-reward profile is "more attractive" for other industrials such as Caterpillar (CAT), which enjoys greater earnings visibility and more cyclical upside.
BLKB Blackbaud
$105.57

1.75 (1.69%)

03/12/18
03/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ranger Energy (RNGR) downgraded to Market Perform from Outperform at Wells Fargo with analyst Judson Bailey saying the growth and margin improvement story he originally forecasted has come in "well below expectations along with disappointing free cash flow." 2. Voyager Therapeutics (VYGR) was downgraded to In Line from Outperform at Evercore ISI and to Neutral from Outperform at Wedbush. 3. HubSpot (HUBS) downgraded to In Line from Outperform at Evercore ISI with analyst Kirk Materne saying he is taking a "few chips off the table" and sees more balanced risk/reward at current levels. 4. XL Group (XL) downgraded to Market Perform from Outperform at JMP Securities with analyst Matthew Carletti saying that he sees low odds of a superior offer following the company's announcement of a deal to be acquired by AXA (AXAHY) for $57.60 per share in cash. 5. Blackbaud (BLKB) downgraded to Underperform from In Line at Evercore ISI with analyst Kirk Materne saying Blackbaud's valuation reflects the current cloud transition and lower tax rate and is full relative to the company's TTM organic growth rate. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/12/18
EVER
03/12/18
DOWNGRADE
Target $100
EVER
Underperform
Blackbaud downgraded to Underperform at Evercore ISI
As previously reported, Evercore ISI downgraded Blackbaud to Underperform from In Line with a $100 price target. Analyst Kirk Materne said Blackbaud's valuation reflects the current cloud transition and lower tax rate and is full relative to the company's TTM organic growth rate.
03/12/18
EVER
03/12/18
DOWNGRADE
EVER
Underperform
Blackbaud downgraded to Underperform from In Line at Evercore ISI
03/15/18
DADA
03/15/18
NO CHANGE
Target $110
DADA
Neutral
Blackbaud price target raised to $110 from $95 at DA Davidson
DA Davidson analyst Rishi Jaluria raised the price target on Blackbaud to $110 after hosting the company's CEO Mike Gianoni for an investor meeting. Jaluria says the management's tone on business performance was positive, with expectations of future opportunities "bigger than in the last four years". The analyst believes that the company's organic revenue growth can accelerate from higher subscriptions and sales organization changes, while its Microsoft partnership can add to that growth over time. Jaluria keeps his Neutral rating on Blackbaud, saying shares are fairly valued on Enterprise Value to Free Cash Flow basis.
IRM Iron Mountain
$35.02

0.385 (1.11%)

01/11/18
DBAB
01/11/18
NO CHANGE
Target $30
DBAB
Sell
Deutsche sees Iron Mountain shares dropping towards $30
Deutsche Bank analyst Kevin McVeigh believes Iron Mountain shares will continue to "grind lower" towards his $30 price after the company closed its recently announced IO Data Centers deal for $1.34B. The analyst continues to believe the deal, which brings the company's lease-adjusted leverage to six times, was done at a "less than optimal multiple." He remains cautious on Iron Mountain shares citing the company's "deteriorating fundamentals" and keeps a Sell rating on the shares.
03/27/18
GSCO
03/27/18
INITIATION
Target $41
GSCO
Buy
Iron Mountain initiated with a Buy at Goldman Sachs
Goldman Sachs analyst George Tong started Iron Mountain with a Buy rating and $41 price target. The analyst rolled out coverage on the Americas Business Services sector with an Attractive rating.
10/18/17
EVER
10/18/17
INITIATION
Target $46
EVER
Outperform
Iron Mountain initiated with an Outperform at Evercore ISI
Evercore ISI analyst initiated Iron Mountain with an Outperform and $46 price target. The analyst said Iron Mountain's dividend yield of 5.5% is one of the highest in large cap REITS and will continue to capture client's storage needs regardless if its is via paper records or digital needs.
NCLH Norwegian Cruise Line
$52.73

0.47 (0.90%)

05/16/18
NOMU
05/16/18
NO CHANGE
Target $69
NOMU
Buy
Norwegian Cruise shares can rally to $69 in near term, says Nomura Instinet
After hosting a chat with CEO Frank Del Rio, Nomura Instinet analyst Harry Curtis believes shares of Norwegian Cruise Line can hit $69 in the near term. Despite concerns regarding fuel expense and supply growth in 2019 and 2020, Norwegian is capable of generating $6 of earrings per share in 2020, Del Rio tells investors in a research note. He believes the stock is attractively valued and keeps a Buy rating on Norwegian Cruise Line.
06/06/18
NOMU
06/06/18
NO CHANGE
NOMU
Nomura Instinet disagrees with Morgan Stanley on cruise lines
Nomura Instinet analyst Harry Curtis says he disagrees with Morgan Stanley's bearish note yesterday on cruise lines. Conversations with industry managements and pricing survey data indicate that Q3 Caribbean weakness is isolated and should be more than offset by stronger yields elsewhere in the globe, Curtis tells investors in a research note. The bear thesis is that weak Caribbean pricing, coupled with unfavorable fuel and currency trends, could lead to substantial earnings guidance misses in the second half of 2018, the analyst adds. He disagrees and believes yields are likely to remain ahead of guidance for 2018.
06/05/18
MSCO
06/05/18
NO CHANGE
MSCO
Travel agents flagging Q4 weakness for cruiselines, says Morgan Stanley
Morgan Stanley analyst Jamie Rollo said his survey of U.S. travel agents shows a weakening picture and his web research shows mixed results for the cruiselines. On the negative side, overall pricing is described as flat, the impact of Kilauea has affected Hawaii bookings, and many agents cite concerns about the Caribbean and general Q4 demand, Rollo tells investors. The analyst, who also said recent strength in oil prices and the U.S. dollar "are a double negative for cruise stocks," cut his FY19 EPS estimate for Carnival (CCL) by 11%, his estimate for Norwegian Cruise Line (NCLH) by 5% and his Royal Caribbean (RCL) estimate by 3%. Rollo lowered his price target on Carnival shares to $63 from $70, his target on Norwegian to $58 from $64 and his target on Royal Caribbean to $110 from $130.
06/11/18
JPMS
06/11/18
NO CHANGE
JPMS
Cruise stocks could reverse positively in near term, says JPMorgan
JPMorgan recently surveyed June pricing for cruise itineraries marketed in the U.S. for select Carnival (CCL), Royal Caribbean (RCL) and Norwegian Cruise Line (NCLH) brands. On a global basis, gross ticket prices for itineraries sailing over the next 12 months were steady for Royal and Norwegian compared to last month while Carnival prices improved 100 basis points compared to last month and are now flat year-over-year, JPMorgan analyst Joseph Greff tells investors in a research note. He notes that on a quarterly basis, and focusing in on the Caribbean, Q3 itineraries were softer sequentially and Europe held steady across all companies. The latest data points on Caribbean pricing are a "mixed bag but mostly softer" compared to last month, while global itinerary prices are holding up well overall, Greff writes. The analyst continues to like shares of Royal Caribbean and Norwegian Cruise Line. He expects cruise stocks could reverse positively over the near term, noting that they tend to outperform in Q3 and Q4.

TODAY'S FREE FLY STORIES

03:05
11/19/18
11/19
03:05
11/19/18
03:05
General news
FX Update: The Dollar has held up »

FX Update: The Dollar has…

JD

JD.com

$23.04

-1.18 (-4.87%)

, SPB

Spectrum Brands

$59.36

0.87 (1.49%)

20:25
11/18/18
11/18
20:25
11/18/18
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

JD

JD.com

$23.04

-1.18 (-4.87%)

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

AAPL

Apple

$193.42

2 (1.04%)

, PCG

PG&E

$24.39

6.62 (37.25%)

19:29
11/18/18
11/18
19:29
11/18/18
19:29
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

AAPL

Apple

$193.42

2 (1.04%)

PCG

PG&E

$24.39

6.62 (37.25%)

CBS

CBS

$57.49

0.23 (0.40%)

VIA

Viacom

$37.05

0.96 (2.66%)

VIAB

Viacom

$33.00

1.13 (3.55%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

TGT

Target

$79.67

-1.09 (-1.35%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TIF

Tiffany

$106.48

0.52 (0.49%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TJX

TJX

$51.47

-0.98 (-1.87%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

LB

L Brands

$35.28

-0.41 (-1.15%)

T

AT&T

$30.30

0.18 (0.60%)

BP

BP

$40.85

-0.3 (-0.73%)

CVX

Chevron

$119.14

2.18 (1.86%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

APC

Anadarko

$56.39

0.9 (1.62%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

AMGN

Amgen

$194.23

1.83 (0.95%)

THS

TreeHouse

$51.92

0.72 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 26

    Nov

  • 27

    Nov

  • 28

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 18

    Jan

  • 22

    Jan

  • 03

    Mar

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

, BX

Blackstone

$32.48

-0.02 (-0.06%)

18:50
11/18/18
11/18
18:50
11/18/18
18:50
Periodicals
Zayo said to get interest from Blackstone-Stonepeak Group, Bloomberg reports »

Zayo (ZAYO) has attracted…

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

BX

Blackstone

$32.48

-0.02 (-0.06%)

KKR

KKR

$21.83

-0.46 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 03

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:08
11/18/18
11/18
18:08
11/18/18
18:08
Periodicals
PG&E reports another outage on morning when California started, Reuters says »

PG&E, facing investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$18.97

0.28 (1.50%)

18:04
11/18/18
11/18
18:04
11/18/18
18:04
Hot Stocks
Kirkland Lake Gold appoints David Soares as CFO, Eric Kallio as senior VP »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPD

Expeditors

$73.67

0.14 (0.19%)

17:19
11/18/18
11/18
17:19
11/18/18
17:19
Conference/Events
Expeditors management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CBS

CBS

$57.49

0.23 (0.40%)

, VIAB

Viacom

$33.00

1.13 (3.55%)

16:54
11/18/18
11/18
16:54
11/18/18
16:54
Periodicals
CBS, Viacom merger could be a few months away, NY Post reports »

After CBS (CBS) CEO Les…

CBS

CBS

$57.49

0.23 (0.40%)

VIAB

Viacom

$33.00

1.13 (3.55%)

VIA

Viacom

$37.05

0.96 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

AIMT

Aimmune

$29.61

0.05 (0.17%)

16:51
11/18/18
11/18
16:51
11/18/18
16:51
Hot Stocks
PALISADE trial of Aimmune's AR101 published in New England Journal of Medicine »

Aimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 12

    Dec

T

AT&T

$30.30

0.18 (0.60%)

, CMCSA

Comcast

$38.60

0.11 (0.29%)

16:31
11/18/18
11/18
16:31
11/18/18
16:31
Hot Stocks
Box Office Battle: 'Fantastic Beasts 2' wins weekend with $62M »

AT&T (T) subsidiary…

T

AT&T

$30.30

0.18 (0.60%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$50.80

-0.81 (-1.57%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

LGF.A

Lionsgate

$20.88

0.365 (1.78%)

DIS

Disney

$116.20

-0.9 (-0.77%)

VIAB

Viacom

$33.00

1.13 (3.55%)

VIA

Viacom

$37.05

0.96 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

, GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

15:45
11/18/18
11/18
15:45
11/18/18
15:45
Periodicals
Volkswagen CEO says Waymo has 1/2-year head start, Reuters reports »

Volkwagen (VLKAY) is up…

VLKAY

Volkswagen

$0.00

(0.00%)

GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

15:21
11/18/18
11/18
15:21
11/18/18
15:21
Hot Stocks
AT&T, Fox Networks renew multi-year deal across distribution platforms »

AT&T (T) and Fox…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

AAPL

Apple

$193.42

2 (1.04%)

13:35
11/18/18
11/18
13:35
11/18/18
13:35
Periodicals
Apple CEO views new regulations as 'inevitable,' Axios reports »

Apple CEO Tim Cook says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

, RIO

Rio Tinto

$50.94

0.89 (1.78%)

13:05
11/18/18
11/18
13:05
11/18/18
13:05
Periodicals
Nespresso, Rio Tinto joining forces to make coffee pods greener, Reuters says »

Nespresso, part of food…

NSRGY

Nestle

$0.00

(0.00%)

RIO

Rio Tinto

$50.94

0.89 (1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$1.11

-0.095 (-7.92%)

12:54
11/18/18
11/18
12:54
11/18/18
12:54
Hot Stocks
Sonoma Pharmaceuticals announces pricing of public offering of units »

Sonoma Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 04

    Dec

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/18/18
11/18
04:55
11/18/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

PDVW

pdvWireless

$39.84

0.06 (0.15%)

16:30
11/17/18
11/17
16:30
11/17/18
16:30
Conference/Events
pdvWireless management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.49

0.23 (0.40%)

16:28
11/17/18
11/17
16:28
11/17/18
16:28
Conference/Events
CBS management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

THS

TreeHouse

$51.92

0.72 (1.41%)

, CAG

Conagra Brands

$33.09

0.66 (2.04%)

12:54
11/17/18
11/17
12:54
11/17/18
12:54
Periodicals
Treehouse Foods stock may have room to gain, Barron's says »

Treehouse Foods (THS)…

THS

TreeHouse

$51.92

0.72 (1.41%)

CAG

Conagra Brands

$33.09

0.66 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$194.23

1.83 (0.95%)

12:51
11/17/18
11/17
12:51
11/17/18
12:51
Periodicals
Amgen may be 'a remedy' for tougher times, Barron's says »

Amgen may be a stock that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

AAPL

Apple

$193.42

2 (1.04%)

, LITE

Lumentum

$41.50

0.46 (1.12%)

12:47
11/17/18
11/17
12:47
11/17/18
12:47
Periodicals
Apple stock could continue to slide, Barron's says »

Apple's (AAPL) stock…

AAPL

Apple

$193.42

2 (1.04%)

LITE

Lumentum

$41.50

0.46 (1.12%)

QRVO

Qorvo

$66.32

1.18 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$56.39

0.9 (1.62%)

, RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

12:41
11/17/18
11/17
12:41
11/17/18
12:41
Periodicals
Investors may find bargains among oil, natural gas stocks, Barron's says »

Investors have been…

APC

Anadarko

$56.39

0.9 (1.62%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

CVX

Chevron

$119.14

2.18 (1.86%)

BP

BP

$40.85

-0.3 (-0.73%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Jan

  • 22

    Jan

LB

L Brands

$35.28

-0.41 (-1.15%)

, JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

12:34
11/17/18
11/17
12:34
11/17/18
12:34
Periodicals
Kohl's, Target set to thrive this holiday season, Barron's says »

Store chains have been…

LB

L Brands

$35.28

-0.41 (-1.15%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

TJX

TJX

$51.47

-0.98 (-1.87%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TIF

Tiffany

$106.48

0.52 (0.49%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TGT

Target

$79.67

-1.09 (-1.35%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

09:18
11/17/18
11/17
09:18
11/17/18
09:18
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.46

-0.12 (-0.72%)

F

Ford

$9.05

-0.26 (-2.79%)

GM

General Motors

$35.76

0.21 (0.59%)

HMC

Honda

$28.21

0.01 (0.04%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$116.87

-0.02 (-0.02%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$26.30

-0.2 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/17/18
11/17
04:55
11/17/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.